Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.
Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…
